Cargando…
Incidence of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome and Impact on Patient Outcome
OBJECTIVES AND DESIGN: We used data from a randomized trial of HIV-tuberculosis co-infected patients in Mozambique to determine the incidence and predictors of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (IRIS) occurring within 12 weeks of starting antiretroviral...
Autores principales: | Bonnet, Maryline, Baudin, Elisabeth, Jani, Ilesh V., Nunes, Elizabete, Verhoustraten, François, Calmy, Alexandra, Bastos, Rui, Bhatt, Nilesh B., Michon, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867516/ https://www.ncbi.nlm.nih.gov/pubmed/24367678 http://dx.doi.org/10.1371/journal.pone.0084585 |
Ejemplares similares
-
Correction: Incidence of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome and Impact on Patient Outcome
por: Bonnet, Maryline, et al.
Publicado: (2014) -
Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship
por: Bhatt, Nilesh B., et al.
Publicado: (2015) -
Cytotoxic Mediators in Paradoxical HIV–Tuberculosis Immune Reconstitution Inflammatory Syndrome
por: Wilkinson, Katalin A., et al.
Publicado: (2015) -
Immune reconstitution inflammatory syndrome: A therapeutic paradox
por: Samson, Joan Felicita, et al.
Publicado: (2012) -
Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy
por: Azam, Khalide, et al.
Publicado: (2022)